Increased level of advanced oxidation protein products in patients with coronary artery disease.
about
Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols.Plasma advanced oxidative protein products are associated with anti-oxidative stress pathway genes and malaria in a longitudinal cohort.Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview.Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetesIncreased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients.Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis.Sickle Cell Trait Worsens Oxidative Stress, Abnormal Blood Rheology, and Vascular Dysfunction in Type 2 DiabetesComparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distressGlucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway.Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney DiseaseCIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling.Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.Plasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester.The relation between intensity and complexity of coronary artery lesion and oxidative stress in patients with acute coronary syndrome.Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability.Biomarkers of oxidative stress in ruminant medicine.Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?Clinical and research markers of oxidative stress in chronic kidney disease.Immunomodulatory basis of antioxidant therapy and its future prospects: an appraisal.The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.Increased Circulating Advanced Oxidation Protein Products and High-Sensitive Troponin T in Cirrhotic Patients with Chronic Hepatitis C: A Preliminary Report.Oxidative/nitrosative stress and protein damages in aqueous humor of hyperglycemic rabbits: effects of two oral antidiabetics, pioglitazone and repaglinide.Increased Advanced Oxidation Protein Products Generation by Cyclosporine-A and Angiotensin II in Human Gingival Fibroblasts - Ex-vivo Study.Oxidative stress: Predictive marker for coronary artery disease.Gender-dependent variations in systemic biomarkers of oxidative protein, DNA, and lipid damage in aged rats.Association between advanced oxidation protein products and 5-year mortality risk among amazon riparian elderly population.Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?Changes in oxidative balance in rat pericytes exposed to diabetic conditions.Implication of xanthine oxidase in muscle oxidative stress in COPD patients.An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer.An alternative pathway through the Fenton reaction for the formation of advanced oxidation protein products, a new class of inflammatory mediators.Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease.Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients.Oxidative status and reduced glutathione levels in premature coronary artery disease and coronary artery disease.Carbonyl groups: Bridging the gap between sleep disordered breathing and coronary artery disease.Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study).Oxidative stress and inflammation in pregnancy
P2860
Q30363344-F965EB7B-9563-4FC3-BAF0-7128B388BD7AQ34501444-242E625D-39D3-4EA0-A298-24F503D73F75Q34781792-B4AEEDA1-BD98-4918-B1FD-380EC8961707Q35073993-7C2E2226-F5BA-48A5-BC43-8B0B20926C70Q35904435-AFBD8460-2B3A-412D-8984-39F913F2134EQ35990746-F3A09217-DFD9-4526-B5B1-34BC7F487411Q36186026-EE0E747C-2044-4A25-AF0D-F6064564D127Q36274244-07B53E6D-2609-4A2A-B570-E4049F6AA022Q36520207-4D8651A2-8DBC-4D4F-9EB8-4F320892E769Q36538869-4502F02F-DBF7-4584-AD0A-49211D60E1D4Q36711861-EA51910C-2274-4E55-9375-872637FFC716Q37023199-C819BE10-39E0-4628-85A0-4ED94F13EEF2Q37190915-905D999A-D10D-49DC-813E-2726E4AB0C67Q37359754-D622A544-7B0A-421C-8280-B8EF5FCEDD29Q37680570-3BF6440C-2C80-4964-BB91-54725A643786Q37742522-BA6AE138-1926-4F29-8B26-9B05E0491901Q37789753-0E0ACA2F-0F4E-43B4-8920-4FE9D923E138Q37899201-80D84BF9-02FD-4BAE-BDC8-303B6C11D9F3Q38075905-D29C7A56-FB56-4B0C-8C35-F2568D286083Q38634055-0ABF5C13-7082-4F12-BA3C-F94087A843BFQ38878978-3A2D0218-FFEC-4024-AFE8-61CA5A7E8E2EQ40872573-C118216E-699A-4200-B2B9-7254F544FB48Q42025887-5AB0FA0B-959A-436D-A81D-81CB46BC4E5CQ42320116-D854FEC6-9712-4765-AF42-71FA5D50479AQ43081749-48FFF037-3F3C-4D7D-B12B-87B3863BF22BQ43250309-53F5E337-6007-419A-9C0F-571D1A90F16EQ44532692-AB000BB4-2CC5-4FFA-8CB4-DA7A9F2E8633Q44786830-E5913E12-7B8A-4CF5-88E8-F9379F8EEBA8Q44848072-5E3A6F44-EC57-4743-97D3-5E8BE7C935DEQ46343728-10D002CD-DE97-438B-B98D-687D6DD9C943Q46874754-8123D410-8BE0-4FBA-924D-E14B99B769C7Q46975168-2D4D2599-824D-43F6-9DFF-55A2CD06B1E1Q47392210-76887787-8885-4667-94EB-9508AD4B93DCQ47447048-AD998F41-55A2-462B-81A7-48332935F6C8Q47816074-1960FCB0-4867-4E0F-B38C-EAAF134BAE07Q48355265-D9844353-C333-41AC-9A0F-E249CEBDD549Q50719651-A081719E-C92A-4B2D-84D4-7541B9E39B7DQ57825373-678346A0-127C-4E5B-B42E-EF853759D307
P2860
Increased level of advanced oxidation protein products in patients with coronary artery disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Increased level of advanced ox ...... with coronary artery disease.
@en
Increased level of advanced ox ...... with coronary artery disease.
@nl
type
label
Increased level of advanced ox ...... with coronary artery disease.
@en
Increased level of advanced ox ...... with coronary artery disease.
@nl
prefLabel
Increased level of advanced ox ...... with coronary artery disease.
@en
Increased level of advanced ox ...... with coronary artery disease.
@nl
P2093
P1433
P1476
Increased level of advanced ox ...... with coronary artery disease.
@en
P2093
Hideaki Kaneda
Junichi Taguchi
Ken Ogasawara
Minoru Ohno
Tadanori Aizawa
P304
P356
10.1016/S0021-9150(01)00706-7
P577
2002-05-01T00:00:00Z